Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Caron A Jacobson,Julio C Chavez,Alison R Sehgal,Basem M William,Javier Munoz,Gilles Salles,Pashna N Munshi,Carla Casulo,David G Maloney,Sven de Vos,Ran Reshef,Lori A Leslie,Ibrahim Yakoub-Agha,Olalekan O Oluwole,Henry Chi Hang Fung,Joseph Rosenblatt,John M Rossi,Lovely Goyal,Vicki Plaks,Yin Yang,Remus Vezan,Mauro P Avanzi,Sattva S Neelapu The Lancet Oncology(2022)
摘要
Kite, a Gilead Company.
更多查看译文
AI 理解论文
溯源树
样例